An impairment in the glymphatic clearance function has been shown to accelerate the accumulation of abluminal protein deposits, α-synuclein, Aβ and tau, and huntingtin, which, respectively, underpin small vessel disease, Parkinson's disease, Alzheimer's disease (AD), and Huntington's disease (13, 14). Here, MAPT is linked to Alzheimer disease.